Literature DB >> 58161

Evaluation of quality of life in patients receiving treatment for advanced breast cancer.

T J Priestman, M Baum.   

Abstract

Linear analogue self-assessment was used to measure the subjective effects of treatment in women with advanced breast cancer. The results show that this technique may be used to monitor the subjective benefit of treatment and to compare the subjective toxicities of different therapeutic regimens. The results also suggest that the subjective toxicity of cytotoxic therapy is not related to the patient's age and diminishes with successive courses of drugs.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 58161     DOI: 10.1016/s0140-6736(76)92112-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  76 in total

1.  Quality of life: philosophical question or clinical reality?

Authors:  M L Slevin
Journal:  BMJ       Date:  1992-08-22

2.  The impact of nausea and vomiting upon quality of life measures.

Authors:  J M Bliss; B Robertson; P J Selby
Journal:  Br J Cancer Suppl       Date:  1992-12

3.  Quality-of-life assessment in small cell lung cancer.

Authors:  P Fayers
Journal:  Pharmacoeconomics       Date:  1992-09       Impact factor: 4.981

Review 4.  Measuring the effect of cancer on health-related quality of life.

Authors:  D Osoba
Journal:  Pharmacoeconomics       Date:  1995-04       Impact factor: 4.981

5.  Testing the interval-level measurement property of multi-item visual analogue scales.

Authors:  Paul F M Krabbe; Peep F M Stalmeier; Leida M Lamers; Jan J V Busschbach
Journal:  Qual Life Res       Date:  2006-09-20       Impact factor: 4.147

Review 6.  Quality of life measurement for patients undergoing treatment for lung cancer.

Authors:  R J Fergusson; A Cull
Journal:  Thorax       Date:  1991-09       Impact factor: 9.139

7.  A randomized multicenter trial of cyclophosphamide, Novantrone and 5-fluorouracil (CNF) versus cyclophosphamide, Adriamycin and 5-fluorouracil (CAF) in patients with metastatic breast cancer.

Authors:  J M Bennett; P Byrne; A Desai; C White; R DeConti; C Vogel; E Krementz; F Muggia; J Doroshow; D Plotkin
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

8.  Laser therapy in the management of benign and malignant tumours in the colon and rectum.

Authors:  N Krasner
Journal:  Int J Colorectal Dis       Date:  1989       Impact factor: 2.571

9.  Comparative trial of endocrine versus cytotoxic treatment in advanced breast cancer.

Authors:  T Priestman; M Baum; V Jones; J Forbes
Journal:  Br Med J       Date:  1977-05-14

10.  Advanced breast cancer treatment with folinic acid, 5-fluorouracil, and mitomycin C.

Authors:  G Francini; R Petrioli; A Aquino; S Gonnelli
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.